Those following PLC

AVN Becomes Russell 2000 Candidate!!!!!

From: JimmyZ.
Date: June 15, 2001
Time: 03:51 AM

Comments

AVN Becomes Russell 2000 Candidate!!!!!

"Advantages: A well diversified index for smaller companies which have great growth potential."

Remember...

AVN Could Be the New Mab Leader

Interesting news in the biotech world has arrived. Eos has signed the first partnership with AVN's Xenerex which will compete with MEDX, ABGX and PDLI in making fully human monoclonal antibodies. What's even more interesting is that Eos' chairman of the board is Nicholas Pritzker and a major investor in Eos is the Pritker Family's BCC bank. The Pritzkers are the multibillionairs of Hyatt Hotel fame who were instumental is the growth of MEDX. The Pritzkers through BCC were one of MEDX's largest investors. Immediately after the deal with AVN, Eos announced that they were retuning $5M to MEDX which was in the terms of an already existing deal. One has to assume that the terms of the contract being changed were in connection with the AVN/Xenerex deal. Why would the Pritzkers lean towards AVN/Xenerex now? Perhaps this has something to do with it...

"Using immuno-deficient mice, rather than transgenic mice, Xenerex can produce completely human antibodies faster and cheaper than its competition, big market players like Abgenix Inc., Medarex Inc. and Cambridge Antibody Technology plc, Hansen said. "

Bioworld Online, Aug 21, 2000

From: DigitalJam2000
Date: February 14, 2000
Time: 11:24 PM

Comments

I'm noticing some positive technical indicators when studying the price/volume of PLC. With the action today, I feel that the stock could be getting ready for a little run up. Those long on the stock should keep a close watch the next couple of days/weeks. This could hopefully provide some of you long with an face saving exit point :-)

Please Note: This discussion is open to all site visitors and is not regulated by Prohost. Information posted in the discussion should not be considered to be coming from Prohost Research.

Prohost is an independent publication providing information on biotech companies. Prohost does not accept compensation from companies that are featured or profiled. It is strongly recommended that any purchase or sale decisions to any of the featured companies be discussed with a financial advisor or broker prior to completing any such purchase or sale decision. All statements or expressions are the opinion of Prohost and are not meant to be a solicitation or recommendation to buy, sell, or hold securities. Investing in embryonic companies, micro-cap and growth securities is highly speculative and carries a high degree of risk. It is possible that an investor can lose all of his/her investment in this type of companies that are profiled. The information that Prohost relies on is either through the profiled company, news services, research reports, interviews, or other outside sources that Prohost believes are reliable. Prohost makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure of the profiled companies and accepts no responsibilities for inaccuracies or misleading content in any material supplied by those clients. There can be no assurance that future events relating to the profiled company will occur as anticipated. The information contained herein is provided as an information service only. Past performance of featured companies does not guarantee the future success of any currently featured or profiled company. We encourage our readers to invest carefully and read the investor information provided by the Securities and Exchange Commission ("SEC") and/or the National Association of Securities Dealers ("NASD"). We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.

Prohost Biotechnology Online

The Newsletter of Biotechnology Research and Investment

P R O H O S T O n l i n e
The Newsletter of Biotechnology Insight and Investment

Biotechnology Discussion